EPHB 4 Gene Polymorphisms and Risk of Intracranial Hemorrhage in Patients With Brain Arteriovenous Malformations
暂无分享,去创建一个
C. McCulloch | P. Kwok | L. Pawlikowska | M. Lawton | W. Young | Yongmei Chen | S. Weinsheimer | S. Sidney | Helen Kim
[1] H. Augustin,et al. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes , 2008, Journal of Cell Science.
[2] Rong A. Wang,et al. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis , 2008, Development.
[3] Shengshou Hu,et al. Arterial–venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation , 2008, FEBS letters.
[4] K. Lunetta. Genetic Association Studies , 2008, Circulation.
[5] N. Barbaro,et al. EVIDENCE OF INFLAMMATORY CELL INVOLVEMENT IN BRAIN ARTERIOVENOUS MALFORMATIONS , 2008, Neurosurgery.
[6] K. Giacomini,et al. Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics , 2008, Clinical pharmacology and therapeutics.
[7] Issam A Awad,et al. CONCEPTS AND HYPOTHESES: INFLAMMATORY HYPOTHESIS IN THE PATHOGENESIS OF CEREBRAL CAVERNOUS MALFORMATIONS , 2007, Neurosurgery.
[8] C. McCulloch,et al. Racial/Ethnic Differences in Longitudinal Risk of Intracranial Hemorrhage in Brain Arteriovenous Malformation Patients , 2007, Stroke.
[9] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[10] Gerard Tromp,et al. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms , 2007, BMC Genomics.
[11] David V Conti,et al. Testing association between disease and multiple SNPs in a candidate gene , 2007, Genetic epidemiology.
[12] H. Drexler,et al. Notch Ligand Delta-Like 1 Is Essential for Postnatal Arteriogenesis , 2007, Circulation research.
[13] J. W. B. van der Sprenkel,et al. Familial occurrence of brain arteriovenous malformations: a systematic review , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[14] Alan M. Moses,et al. In vivo enhancer analysis of human conserved non-coding sequences , 2006, Nature.
[15] A. A. Romanovsky,et al. Putative dual role of ephrin‐Eph receptor interactions in inflammation , 2006, IUBMB life.
[16] Peter Libby,et al. Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[17] Santhosh K. P. Kumar,et al. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. , 2006, Blood.
[18] Peter Vajkoczy,et al. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis , 2006, The EMBO journal.
[19] S. Gabriel,et al. Efficiency and power in genetic association studies , 2005, Nature Genetics.
[20] J. Mohr,et al. Brain arteriovenous malformations in adults , 2005, The Lancet Neurology.
[21] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[22] C. McCulloch,et al. Polymorphisms in Genes Involved in Inflammatory and Angiogenic Pathways and the Risk of Hemorrhagic Presentation of Brain Arteriovenous Malformations , 2004, Stroke.
[23] H. Augustin,et al. Inhibition of tumor growth and angiogenesis by soluble EphB4. , 2004, Neoplasia.
[24] E. Pasquale,et al. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[25] B. Weir,et al. Properties of the Multiallelic Trend Test , 2004, Biometrics.
[26] H. Dressman,et al. Gene Microarray Analysis of Human Brain Arteriovenous Malformations , 2004, Neurosurgery.
[27] Wen-Chung Lee,et al. Searching for disease-susceptibility loci by testing for Hardy-Weinberg disequilibrium in a gene bank of affected individuals. , 2003, American journal of epidemiology.
[28] Issam A Awad,et al. Differential Gene Expression in Human Cerebrovascular Malformations , 2003, Neurosurgery.
[29] R. Adams. Molecular control of arterial–venous blood vessel identity , 2003, Journal of anatomy.
[30] G. Yancopoulos,et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. , 2001, Developmental biology.
[31] E. Pasquale,et al. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization , 2000, Oncogene.
[32] D. Anderson,et al. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. , 1999, Molecular cell.
[33] M. Taneda,et al. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. , 1999, Stroke.
[34] F. Diella,et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. , 1999, Genes & development.
[35] A. Andres,et al. Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. , 1998, Journal of cell science.
[36] David J. Anderson,et al. Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.
[37] N. Risch,et al. A comparison of linkage disequilibrium measures for fine-scale mapping. , 1995, Genomics.
[38] Pui-Yan Kwok,et al. Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. , 2006, Stroke.
[39] T. M. Hsu,et al. Homogeneous primer extension assay with fluorescence polarization detection. , 2003, Methods in molecular biology.
[40] M. Dichgans,et al. Section Editors: the Genetic Architecture of Intracerebral Hemorrhage , 2022 .